Oklahoma, US-based anti-abortion craft store chain Hobby Lobby stirred controversy by investing $73 million in Pfizer, Bayer, and other companies that make abortive drugs and contraception.
Tags: Pfizer
Drugmakers may need indemnity for fast-tracked Ebola vaccines
Drugmakers are looking for some kind of indemnity from governments or multilateral agencies against possible losses or claims arising from the widespread emergency use of new Ebola vaccines in Africa.
AstraZeneca looks to EU decision for next cancer drug boost
AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
Hundreds of firms join global hunt for copycat biotech drugs
Hundreds of companies around the world are chasing an emerging market for cheaper copies of costly biotech drugs, with more than 700 so-called biosimilars now in development or already approved, according to a major study of the sector.
AstraZeneca, Shire fall as U.S. tax move punctures deal hopes
Shares in drugmakers AstraZeneca (AZN.L) and Shire (SHP.L) both fell more than 5 percent on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad.
Latest News
After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.
Ben Venue Laboratories, a subsidiary of German Boehringer Ingelheim in the US, has engaged Bank of American Merill Lynch to advise it on a proposed sale of its sterile injectable drugs business.
Merck & Co. decided to cut its annual spending by USD2.5 billion and eliminate more than 10% of its global workers.
Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.
Pfizer invests in two plants in Ireland. A company restructuring in Pfizer's two plants went underway as the pharmaceutical giant announced that a US$130 million investment is heading their way.
Pharmaceutical giant Pfizer Inc. (PFE) announced it had reached a settlement worth $2.15 billion with Teva Pharmaceutical Industries Ltd. (TEVA) and Sun Pharmaceutical Industries Ltd. (SUNP) after almost a decade of trials over Protonix sales in the United States.
Pfizer would be offering a voluntary stock exchange program with current shareholders for Zoetis shares.
Merck and Pfizer announce deal for the inclusion of ertugliflozin into current diabetes drug portfolios of the companies.
The Mexican Federal Competition Commission has disallowed Pfizer from using Pfizer baby food brands for twenty years.
